Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Depakote/Depakote Sprinkle · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Sequence Group I | EXPERIMENTAL | Depakote Delayed Release/Depakote Sprinkle |
| Sequence Group II | EXPERIMENTAL | Depakote ER |
| Name | Type | Description |
|---|---|---|
| Depakote Delayed-Release/Depakote Sprinkle | DRUG | Administered according to the subject's usual regimen. |
| Depakote ER | DRUG | Dose converted to 8-20% higher than Depakote DR or Depakote Sprinkle. |
Inclusion Criteria: * Male or female patient with a clinical diagnosis of epilepsy considered stable by the investigator. * Must be in good physical health, on the same dose of all medications, including Depakote and other AEDs, for 2 week period prior to randomization. * Minimum body weight of 37 ...
Depakote/Depakote Sprinkle is a small molecule being studied for the treatment of pediatric epilepsy. It is an investigational drug in clinical development for this condition, specifically in children and adolescents. The drug is not approved for this use and remains under investigation.
Depakote/Depakote Sprinkle is being developed by Abbott Laboratories, a company traded on the New York Stock Exchange under the ticker ABT. The company is conducting clinical research to evaluate the drug's safety and efficacy in pediatric epilepsy patients.
Depakote/Depakote Sprinkle is in Phase 2 clinical development for pediatric epilepsy. It is an investigational drug, meaning it has not been approved by regulatory authorities and is still being studied in clinical trials to assess its effects in the target patient population.
Depakote/Depakote Sprinkle has been studied in one completed clinical trial, NCT00646711, titled "Pediatric Switch Study for Children and Adolescent Patients With Epilepsy." This Phase 2 trial enrolled 16 participants in the United States, with a minimum age of 6 years, and included both male and female patients.
Yes, Depakote/Depakote Sprinkle is the same drug as Depakote Sprinkle. The name Depakote/Depakote Sprinkle is used to refer to the drug, which is also known by the shorter name Depakote Sprinkle. Both names refer to the same investigational small molecule being developed for pediatric epilepsy.